| Q37111842 | A semiautomatic CT-based ensemble segmentation of lung tumors: comparison with oncologists' delineations and with the surgical specimen |
| Q39803701 | Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human non-small cell lung cancer cells |
| Q46401930 | Apoptosis-inducing high (.)NO concentrations are not sustained either in nascent or in developed cancers |
| Q33517827 | Bronchoscopic evaluation of the mediastinum using endobronchial ultrasound: a description of the first 216 cases carried out at an Australian tertiary hospital |
| Q36253530 | Caveolins and lung function |
| Q30355939 | Clinical Translation of Nanomedicine. |
| Q37614572 | Combination of radiotherapy and chemotherapy in locally advanced NSCLC. |
| Q37853481 | Combination of radiotherapy and targeted therapies in the treatment of locally advanced non-small cell lung cancer |
| Q50046179 | Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs |
| Q36097945 | Complex cisplatin-double strand break (DSB) lesions directly impair cellular non-homologous end-joining (NHEJ) independent of downstream damage response (DDR) pathways |
| Q48353696 | Concurrent chemoradiotherapy with weekly nedaplatin versus radiotherapy alone in elderly patients with non-small-cell lung cancer |
| Q36855596 | DNA damage response (DDR) pathway engagement in cisplatin radiosensitization of non-small cell lung cancer |
| Q55506344 | DNA repair capacity correlates with standardized uptake values from 18F-fluorodeoxyglucose positron emission tomography/CT in patients with advanced non–small-cell lung cancer. |
| Q53297277 | Diagnostic Concordance of Histologic Lung Cancer Type Between Bronchial Biopsy and Cytology Specimens Taken During the Same Bronchoscopic Procedure |
| Q60922308 | Does the presence of emphysema increase the risk of radiation pneumonitis in lung cancer patients? |
| Q34016351 | Economics of treatments for non-small cell lung cancer |
| Q84879558 | Emerging developments of chemoradiotherapy in stage III NSCLC |
| Q35269285 | Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism. |
| Q37620345 | Gefitinib: a review of its use in the treatment of locally advanced/metastatic non-small cell lung cancer |
| Q36051715 | Human leukocyte antigen (HLA)-G gene polymorphism in patients with non-small cell lung cancer |
| Q34044082 | INSPIRE: A phase III study of the BLP25 liposome vaccine (L-BLP25) in Asian patients with unresectable stage III non-small cell lung cancer |
| Q24194081 | Immunotherapy for stage I-III non-small cell lung cancer treated with surgery or radiotherapy with curative intent |
| Q36113767 | Induction chemoradiotherapy followed by surgical resection for clinical T3 or T4 locally advanced non-small cell lung cancer |
| Q37977438 | Inoperable stage III non-small cell lung cancer: Current treatment and role of vinorelbine |
| Q36603426 | Investigating the Radioresistant Properties of Lung Cancer Stem Cells in the Context of the Tumor Microenvironment |
| Q37666267 | Lung Cancer OncoGuia |
| Q37897353 | Lung cancer staging: an overview of the new staging system and implications for radiographic clinical staging |
| Q33554085 | Lung cancer: current diagnosis and treatment |
| Q47150627 | Management of occult malignant pleural disease firstly detected at thoracotomy for non-small cell lung cancer patients |
| Q36859958 | Molecularly targeted therapies for advanced or metastatic non-small-cell lung carcinoma |
| Q36860835 | Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time? |
| Q45928445 | Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial. |
| Q30702531 | Nodal Upstaging Is More Common with Thoracotomy than with VATS During Lobectomy for Early-Stage Lung Cancer: An Analysis from the National Cancer Data Base |
| Q50050164 | Non-conventional radiotherapy versus conventional radiotherapy for inoperable non-small-cell lung cancer: A meta-analysis of randomized clinical trials |
| Q47116760 | Normal lung sparing Tomotherapy technique in stage III lung cancer |
| Q44401905 | Outcomes after adjuvant platinum-based chemotherapy in elderly NSCLC patients with T4 disease |
| Q44174829 | Pattern of loco-regional failure after definitive radiotherapy for non-small cell lung cancer |
| Q92110425 | Preliminary Clinical Study of the Differences Between Interobserver Evaluation and Deep Convolutional Neural Network-Based Segmentation of Multiple Organs at Risk in CT Images of Lung Cancer |
| Q58120049 | Prognostic and Added Value of Echocardiographic Strain for Prediction of Adverse Outcomes in Patients with Locally Advanced Non-Small Cell Lung Cancer after Radiotherapy |
| Q88221648 | Prognostic and predictive value of plasma D-dimer in advanced non-small cell lung cancer patients undergoing first-line chemotherapy |
| Q38258751 | Proton beam therapy for locally advanced lung cancer: A review |
| Q35103355 | Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemi |
| Q36325572 | Radiation pneumonitis in patients with lung and mediastinal tumours: a retrospective study of risk factors focused on pulmonary emphysema |
| Q84608831 | Results of Superior Vena Cava Reconstruction With Externally Stented-Polytetrafluoroethylene Vascular Prostheses |
| Q38925887 | Risk-stratifying capacity of PET/CT metabolic tumor volume in stage IIIA non-small cell lung cancer |
| Q38539574 | Robotic-Assisted Thoracic Surgery for Early-Stage Lung Cancer: A Review |
| Q43561521 | Sequential chemoradiotherapy with accelerated hypofractionated radiotherapy compared to concurrent chemoradiotherapy with standard radiotherapy for locally advanced non-small cell lung cancer |
| Q40585488 | Serum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancer |
| Q84582193 | Surgical treatment of stage III non-small cell lung cancer |
| Q83822490 | The optimal chemotherapy for stage III non-small cell lung cancer patients |
| Q36384058 | Treatment outcome and toxicity of intensity-modulated (chemo) radiotherapy in stage III non-small cell lung cancer patients |
| Q35062350 | Treatment recommendations for locally advanced, non-small-cell lung cancer: the influence of physician and patient factors |
| Q48222591 | US-guided core-needle biopsy versus US-guided fine-needle aspiration of suspicious cervical lymph nodes for staging workup of non-head and neck malignancies: A propensity score matching study |
| Q34637882 | Using pet-ct to reduce futile thoracotomy rates in non-small-cell lung cancer: a population-based review |